Raras
Buscar doenças, sintomas, genes...
Doença da biossíntese dos plasmalogênios
ORPHA:3276DOENÇA RARA

Condrodisplasia punctata (CDP) corresponde a um grupo misto de displasias ósseas raras caracterizadas por calcificações puntiformes afetando principalmente as cartilagens epifisárias. A CDP é diagnosticada geralmente durante o primeiro ano de vida, sendo acompanhada de mau prognóstico. A CDP encontra-se frequentemente associadas a encurtamento dos membros, fissuras coronais em vértebras da coluna torácica e lombar, microcefalia e atraso de crescimento, mobilidade articular restrita, catarata, ictiose, alopécia, alterações do sistema nervoso, retardo psicomotor, dificuldade de sucção e deglutição, deficiência auditiva e visual, convulsões, hipoplasia do nervo óptico, cifoescoliose e espinha bífida.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

Doença rara caracterizada por deficiência na produção de plasmalogênios, levando a rizomelia, microcefalia progressiva, atrofia cerebelar e dificuldades motoras severas. Afeta o desenvolvimento neurológico e físico, com manifestações como catarata juvenil e alterações faciais.

🏥
SUS: Cobertura mínimaScore: 5%
Triagem neonatal (Fase 5)
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

🧠
Neurológico
19 sintomas
🦴
Ossos e articulações
19 sintomas
😀
Face
18 sintomas
👁️
Olhos
8 sintomas
💪
Músculos
6 sintomas
🧬
Pele e cabelo
4 sintomas

+ 30 sintomas em outras categorias

Características mais comuns

Rizomelia
Dificuldade para ficar em pé
Catarata juvenil
Microcefalia progressiva
Formato facial anormal
Nariz curto
114sintomas
Sem dados (114)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 114 características clínicas mais associadas, ordenadas por frequência.

RizomeliaRhizomelia
Dificuldade para ficar em péDifficulty standing
Catarata juvenilJuvenile cataract
Microcefalia progressivaProgressive microcephaly
Formato facial anormalAbnormal facial shape

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa6
Últimos 10 anos200publicações
Pico202238 papers
Linha do tempo
20202020Hoje · 2026📈 2022Ano de pico
Publicações por ano (últimos 10 anos)

Triagem neonatal (Teste do Pezinho)

👶
Teste: qPCR para deleção de SMN1 em sangue seco
Fase 5 do PNTNpending
Incidência no Brasil: 1:10.000

A triagem neonatal permite diagnóstico precoce e início imediato do tratamento.

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

5 genes identificados com associação a esta condição.

GNPATDihydroxyacetone phosphate acyltransferaseDisease-causing germline mutation(s) inRestrito
FUNÇÃO

Dihydroxyacetonephosphate acyltransferase catalyzing the first step in the biosynthesis of plasmalogens, a subset of phospholipids that differ from other glycerolipids by having an alkyl chain attached through a vinyl ether linkage at the sn-1 position of the glycerol backbone, and which unique physical properties have an impact on various aspects of cell signaling and membrane biology

LOCALIZAÇÃO

Peroxisome membrane

VIAS BIOLÓGICAS (1)
Plasmalogen biosynthesis
MECANISMO DE DOENÇA

Rhizomelic chondrodysplasia punctata 2

A form of rhizomelic chondrodysplasia punctata, a disease characterized by severely disturbed endochondral bone formation, rhizomelic shortening of femur and humerus, vertebral disorders, dwarfism, cataract, cutaneous lesions, facial dysmorphism, and severe intellectual disability with spasticity.

EXPRESSÃO TECIDUAL(Ubíquo)
Músculo esquelético
65.5 TPM
Linfócitos
55.7 TPM
Cólon sigmoide
50.2 TPM
Testículo
47.5 TPM
Fibroblastos
47.0 TPM
OUTRAS DOENÇAS (1)
rhizomelic chondrodysplasia punctata type 2
HGNC:4416UniProt:O15228
PEX5Peroxisomal targeting signal 1 receptorDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Receptor that mediates peroxisomal import of proteins containing a C-terminal PTS1-type tripeptide peroxisomal targeting signal (SKL-type) (PubMed:11101887, PubMed:11336669, PubMed:12456682, PubMed:16314507, PubMed:17157249, PubMed:17428317, PubMed:21976670, PubMed:26344566, PubMed:7706321, PubMed:7719337, PubMed:7790377). Binds to cargo proteins containing a PTS1 peroxisomal targeting signal in the cytosol, and translocates them into the peroxisome matrix by passing through the PEX13-PEX14 dock

LOCALIZAÇÃO

Cytoplasm, cytosolPeroxisome matrix

VIAS BIOLÓGICAS (1)
Pexophagy
MECANISMO DE DOENÇA

Peroxisome biogenesis disorder 2A

A fatal peroxisome biogenesis disorder belonging to the Zellweger disease spectrum and characterized clinically by severe neurologic dysfunction with profound psychomotor retardation, severe hypotonia and neonatal seizures, craniofacial abnormalities, liver dysfunction, and biochemically by the absence of peroxisomes. Additional features include cardiovascular and skeletal defects, renal cysts, ocular abnormalities, and hearing impairment. Most severely affected individuals with the classic form of the disease (classic Zellweger syndrome) die within the first year of life.

EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
77.7 TPM
Cerebelo
49.0 TPM
Cérebro - Hemisfério cerebelar
48.3 TPM
Pituitária
46.8 TPM
Nervo tibial
44.2 TPM
OUTRAS DOENÇAS (5)
peroxisome biogenesis disorder 2Brhizomelic chondrodysplasia punctata type 5peroxisome biogenesis disorder 2A (Zellweger)Zellweger spectrum disorders
HGNC:9719UniProt:P50542
PEX7Peroxisomal targeting signal 2 receptorDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Receptor required for the peroxisomal import of proteins containing a C-terminal PTS2-type peroxisomal targeting signal (PubMed:11931631, PubMed:22057399, PubMed:25538232, PubMed:9090381). Specifically binds to cargo proteins containing a PTS2 peroxisomal targeting signal in the cytosol (PubMed:11931631, PubMed:22057399, PubMed:25538232). Cargo protein-binding triggers interaction with PEX5 and formation of a ternary complex composed of PEX5 and PEX7 along with PTS2-containing cargo proteins, wh

LOCALIZAÇÃO

Cytoplasm, cytosolPeroxisome matrix

VIAS BIOLÓGICAS (1)
Peroxisomal protein import
MECANISMO DE DOENÇA

Peroxisome biogenesis disorder complementation group 11

A peroxisomal disorder arising from a failure of protein import into the peroxisomal membrane or matrix. The peroxisome biogenesis disorders (PBD group) are genetically heterogeneous with at least 14 distinct genetic groups as concluded from complementation studies. Include disorders are: Zellweger syndrome (ZWS), neonatal adrenoleukodystrophy (NALD), infantile Refsum disease (IRD), and classical rhizomelic chondrodysplasia punctata (RCDP). ZWS, NALD and IRD are distinct from RCDP and constitute a clinical continuum of overlapping phenotypes known as the Zellweger spectrum (PBD-ZSS).

EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
20.5 TPM
Glândula adrenal
18.8 TPM
Skin Sun Exposed Lower leg
17.0 TPM
Skin Not Sun Exposed Suprapubic
16.2 TPM
Estômago
14.2 TPM
OUTRAS DOENÇAS (3)
peroxisome biogenesis disorder 9Brhizomelic chondrodysplasia punctata type 1adult Refsum disease
HGNC:8860UniProt:O00628
AGPSAlkyldihydroxyacetonephosphate synthase, peroxisomalDisease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Catalyzes the exchange of the acyl chain in acyl-dihydroxyacetonephosphate (acyl-DHAP) for a long chain fatty alcohol, yielding the first ether linked intermediate, i.e. alkyl-dihydroxyacetonephosphate (alkyl-DHAP), in the pathway of ether lipid biosynthesis

LOCALIZAÇÃO

Peroxisome membranePeroxisome

VIAS BIOLÓGICAS (2)
Plasmalogen biosynthesisTYSND1 cleaves peroxisomal proteins
MECANISMO DE DOENÇA

Rhizomelic chondrodysplasia punctata 3

A form of rhizomelic chondrodysplasia punctata, a disease characterized by severely disturbed endochondral bone formation, rhizomelic shortening of femur and humerus, vertebral disorders, dwarfism, cataract, cutaneous lesions, facial dysmorphism, and severe intellectual disability with spasticity.

OUTRAS DOENÇAS (1)
rhizomelic chondrodysplasia punctata type 3
HGNC:327UniProt:O00116
FAR1Fatty acyl-CoA reductase 1Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Catalyzes the reduction of saturated and unsaturated C16 or C18 fatty acyl-CoA to fatty alcohols (PubMed:15220348, PubMed:24108123, PubMed:35238077). It plays an essential role in the production of ether lipids/plasmalogens which synthesis requires fatty alcohols (PubMed:20071337, PubMed:24108123, PubMed:33239752). In parallel, it is also required for wax monoesters production since fatty alcohols also constitute a substrate for their synthesis (By similarity) (PubMed:24108123, PubMed:35238077)

LOCALIZAÇÃO

Peroxisome membrane

VIAS BIOLÓGICAS (1)
Wax biosynthesis
MECANISMO DE DOENÇA

Peroxisomal fatty acyl-CoA reductase 1 disorder

An autosomal recessive metabolic disorder clinically characterized by severe intellectual disability, early-onset epilepsy, microcephaly, congenital cataracts, growth retardation, and spasticity.

VIAS REACTOME (1)
EXPRESSÃO TECIDUAL(Ubíquo)
Brain Spinal cord cervical c-1
60.3 TPM
Esôfago - Mucosa
59.2 TPM
Nervo tibial
58.9 TPM
Vagina
49.5 TPM
Útero
47.1 TPM
INTERAÇÕES PROTEICAS (4)
OUTRAS DOENÇAS (2)
spastic paraparesis-cataracts-speech delay syndromefatty acyl-CoA reductase 1 deficiency
HGNC:26222UniProt:Q8WVX9

Variantes genéticas (ClinVar)

449 variantes patogênicas registradas no ClinVar.

🧬 GNPAT: NM_014236.4(GNPAT):c.1285A>T (p.Lys429Ter) ()
🧬 GNPAT: NM_014236.4(GNPAT):c.647_659dup (p.Trp220Ter) ()
🧬 GNPAT: GRCh37/hg19 1q21.1-44(chr1:143932350-249224684)x3 ()
🧬 GNPAT: NM_014236.4(GNPAT):c.772+5G>T ()
🧬 GNPAT: NM_014236.4(GNPAT):c.1602+1G>A ()
Ver todas no ClinVar

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Doença da biossíntese dos plasmalogênios

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

Pesquisa e ensaios clínicos

Nenhum ensaio clínico registrado para esta condição.

🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
0 papers (10 anos)
#1

Plasmalogen deficiency and the Alzheimer's disease risk of apolipoprotein E4.

Brain communications2026

The ε4 allele of the APOE gene, encoding the E4 isoform of apolipoprotein E, is the leading genetic risk factor for late-onset Alzheimer's disease. While many potential mechanisms have been proposed to explain this risk, no dominant or unifying process has yet emerged. Here, we explore the primary function of apolipoprotein E in lipid transport and metabolism, by examining its lipid association properties, to establish whether they show isoform dependence and thereby could mediate Alzheimer's risk. We focus on ethanolamine plasmalogen, a phospholipid subclass known to be depleted in Alzheimer's disease brain. We purified apolipoprotein E from human cerebrospinal fluid by immunoprecipitation using an anti-pan-apolipoprotein E monoclonal antibody bound to magnetic beads, then conducted lipidomic and proteomic analyses of the precipitates by mass spectrometry. The cerebrospinal fluid samples were obtained from cognitively intact, relatively young individuals with no evidence of amyloid pathology and with known apolipoprotein E isoform status (E3E3, n = 5; E3E4, n = 4; E4E4, n = 5). The molar ratio of ethanolamine plasmalogen to apolipoprotein E was 29.5% lower for E4E4 than for E3E3 (P = 0.007) with a biological gradient: E3E3 > E3E4 > E4E4 (P = 0.03). No similar trends and differences were found for phosphatidyl ethanolamine, a chemically related lipid (P = 0.5). Compared to E3E3, the molar ratio of ethanolamine plasmalogen to phosphatidyl ethanolamine was significantly reduced for E3E4 (P = 0.0016) and E4E4 (P = 0.0001). The latter deficiency was similar in magnitude to that found in Alzheimer's disease brain relative to control. The finding that ethanolamine plasmalogen is depleted in apolipoprotein E4 relative to E3 strengthens the view that brain deficiency of this same lipid contributes to Alzheimer's disease causation, rather than being an effect of the neurodegeneration. Simultaneously, these results supply a potential mechanism for the risk of E4 versus E3, the former being less able to counteract the tissue defect. The apolipoprotein E4 lipid depletion cannot itself be a consequence of Alzheimer's disease, since cerebrospinal fluid samples were taken from individuals with no evidence of the condition. The biological gradient in ethanolamine plasmalogen deficiency mirrors the relationship of Alzheimer's disease risk (odds ratio) to E4 allelic dose. Ethanolamine plasmalogen deficiency could be linked to, or indeed drive, several metabolic pathways implicated in Alzheimer's pathogenesis, including amyloid-beta deposition and cholesterol dysregulation. Future studies should extend approaches to therapeutic intervention in Alzheimer's disease which attempt to reverse this lipid abnormality.

#2

Peroxisomes in Aging: Guardians of Cellular Resilience and Function.

Cells2026 Jan 28

Peroxisomes are multifunctional organelles that play essential roles in lipid metabolism, redox regulation, and cellular signaling. An expanding body of evidence implicates peroxisomal dysfunction as a key contributor to aging and age-related diseases. Aging is accompanied by progressive declines in key peroxisomal functions, including catalase activity, fatty acid β-oxidation, plasmalogen biosynthesis, and the metabolism of bile acids and docosahexaenoic acid, resulting in increased oxidative stress, lipid dysregulation, and alterations in membrane composition. Impaired pexophagy further exacerbates these defects by allowing the accumulation of damaged peroxisomes and compromising cellular homeostasis. Through extensive metabolic and signaling crosstalk with mitochondria, the endoplasmic reticulum, and lysosomes, peroxisomal dysfunction can propagate oxidative and metabolic disturbances throughout the cell. In addition, peroxisome-derived signaling molecules, such as hydrogen peroxide and bioactive lipids, link peroxisomal activity to cellular stress responses and organismal metabolic homeostasis. We propose that aging-associated impairments in peroxisomal protein import, redox regulation, and selective turnover progressively shift peroxisomes from adaptive metabolic signaling hubs toward sources of chronic oxidative and lipid stress. In this context, current studies highlight peroxisomal homeostasis as a potential determinant of healthy aging and point to peroxisomal pathways as emerging targets for intervention in age-related disease.

#3

CRISPR knockout screens reveal genes and pathways essential for neuronal differentiation and implicate PEDS1 in neurodevelopment.

Nature neuroscience2026 Mar

Neurodevelopmental disorders (NDDs) arise from disruptions in brain development, yet the underlying pathways remain incompletely understood. Here we demonstrate that genome-wide CRISPR knockout screens in mouse embryonic stem cells differentiating into neural lineages identify hundreds of essential genes, only a minority of which are currently implicated in NDDs. Dominant NDD genes were enriched for transcriptional regulators, whereas recessive NDD genes were predominantly involved in metabolic processes. Mouse models for eight genes (Eml1, Dusp26, Dynlrb2, Mta3, Peds1, Sgms1, Slitrk4 and Vamp3) revealed marked neuroanatomical abnormalities, including microcephaly in half of the cases. Focusing on PEDS1, a key enzyme in plasmalogen biosynthesis, we identified a bi-allelic variant in individuals with microcephaly, global developmental delay and congenital cataracts. In mice, Peds1 deficiency led to accelerated cell-cycle exit and impaired neuronal differentiation and migration. These pathways required for neural differentiation provide a genetic framework for discovering additional NDD genes.

#4

Lipidomic remodeling of the brain and muscle in a zebrafish model of depression.

Journal of affective disorders2026 Mar 16

Major depressive disorder (MDD) is a highly prevalent and disabling psychiatric condition, increasingly recognized as a systemic disorder involving central and peripheral pathophysiological alterations. In this study, we used a multidimensional approach using zebrafish (Danio rerio) exposed to an unpredictable chronic stress (UCS) protocol as a model of MDD, to unravel the plasticity of the lipidome in this mental disorder. Behavioral analyses revealed a reduction in sociability and locomotor activity in stressed animals, accompanied by significantly elevated cortisol levels. Fatty acid profiling demonstrated a decrease in n-3 (omega-3) polyunsaturated fatty acids (PUFA) and an increase in n-3 (omega-6) PUFA, which was more evident in the brain than in the muscle. After UCS, lipidomic analysis revealed a remodeling of the brain lipid profile, including the modulation of several phospholipid and sphingolipid species that may impact cell membrane properties and cause neuronal dysfunction. Some of these species have been previously correlated with neuroinflammation and impaired neurotransmission. An increase in plasmalogen phospholipids, well-known endogenous oxidant signaling molecules, suggests a dysregulation of the redox state. In muscle, lipidomic alterations were characterized by elevated levels of acylcarnitines, indicative of altered mitochondrial energy metabolism, and ceramides, well-known pro-inflammatory and pro-apoptotic molecules. This study highlights the relevance of lipidomic plasticity in the pathophysiology of MDD, associated with behavioral effects similar to MDD symptoms.

#5

Quantification and Localisation of New Brain Lipid Synthesis Using Deuterium Oxide and High Resolution Mass Spectrometry.

Angewandte Chemie (International ed. in English)2026 Mar 15

Myelin is the lipid-rich membrane that surrounds neuronal axons and is essential for neurological function in vertebrates. The development of therapeutics that stimulate myelin repair to treat demyelinating disorders such as multiple sclerosis is hampered by the inability to distinguish newly synthesised from pre-existing myelin. This study aimed to develop a method to quantify and localise new myelin lipid synthesis in the mouse brain. Deuterium oxide was administered for two weeks in the drinking water of mice fed normal chow, chow containing the demyelinating toxin cuprizone, or during spontaneous remyelination following cuprizone withdrawal. Liquid chromatography-tandem mass spectrometry and mass spectrometry imaging were used to quantify and localise the newly synthesised, deuterated lipids. While most glycerophospholipids were constitutively deuterated, deuteration of myelin-enriched sulfatides, hexosylceramides, and phosphatidylethanolamine plasmalogens was only apparent during remyelination. Most deuterium atoms were found in the fatty acyl chains, indicative of de novo lipid synthesis. Deuterated hexosylceramide and phosphatidylethanolamine plasmalogen species were localised primarily to the corpus callosum, the white matter tract that is most heavily affected by cuprizone. The method described herein provides the means to quantify and spatially profile dynamic lipid synthesis across diverse biological contexts, including understanding myelin homeostasis and preclinical evaluation of remyelinating therapeutics.

Publicações recentes

Ver todas no PubMed

📚 EuropePMCmostrando 200

2026

Lipidomic remodeling of the brain and muscle in a zebrafish model of depression.

Journal of affective disorders
2026

Quantification and Localisation of New Brain Lipid Synthesis Using Deuterium Oxide and High Resolution Mass Spectrometry.

Angewandte Chemie (International ed. in English)
2026

Longitudinal analysis of lipid changes in the sciatic nerve caused by overexpression of PMP22 in murine models of CMT1A.

Journal of lipid research
2026

Plasmalogen deficiency and the Alzheimer's disease risk of apolipoprotein E4.

Brain communications
2026

Neuronal lipidome in schizophrenia and metabolic syndrome: Potential interventions.

Progress in neuro-psychopharmacology & biological psychiatry
2026

Liver Metabolomic Profiling Reveals Distinct Signatures Between Steatosis and Metabolic Dysfunction-Associated Steatohepatitis.

Liver international : official journal of the International Association for the Study of the Liver
2026

Peroxisomes in Aging: Guardians of Cellular Resilience and Function.

Cells
2025

Lipid and immune dysregulation and risk of metabolic disorders after HCV clearance in HIV/HCV-coinfected participants with cACLD: a retrospective study.

Frontiers in immunology
2025

Metabolomic Profiling Reveals Brain Lipid Alterations in PEX7-Deficient Models of Rhizomelic Chondrodysplasia Punctata.

Biomolecules
2026

Phospholipid Profiling Established by Structure-Rich Fragments for Molecular Species Level Shotgun Analysis.

Rapid communications in mass spectrometry : RCM
2025

Cerebrospinal fluid metabolomic signatures in paediatric MOGAD and POMS.

Frontiers in immunology
2026

CRISPR knockout screens reveal genes and pathways essential for neuronal differentiation and implicate PEDS1 in neurodevelopment.

Nature neuroscience
2026

Characterising the effect of circulating sphingolipids on metastatic prostate cancer cells.

EBioMedicine
2025

Vegetarian Dietary Patterns and Diet-Related Metabolites Are Associated With Kidney Function in the Adventist Health Study-2 Cohort.

Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation
2025

The Changes in Plasmalogens: Chemical Diversity and Nutritional Implications-A Narrative Review.

Nutrients
2025

Multi-omic analysis reveals lipid dysregulation associated with mitochondrial dysfunction in parkinson's disease brain.

Nature communications
2026

Ferroptosis in Tubular Epithelial Cells Across Distinct Renal Regions Is a Primary Causal Factor for Lupus Nephritis.

Antioxidants & redox signaling
2025

Plasmalogens as biomarkers and therapeutic targets.

Journal of lipid research
2026

Metabolomic biomarkers of rest-activity rhythms in older men: results from the Osteoporotic Fractures in Men (MrOS) study.

Sleep
2026

Metabolomic biomarkers of rest-activity rhythms in older women: results from the Women's Health Initiative study.

Sleep
2025

Impact of APOE on cerebrovascular lipid profile in Alzheimer's disease.

Acta neuropathologica
2025

Acyl-CoA Reductase Far1 Deficiency Impairs Ether Lipid Production and Hypomyelination in Mouse Brains.

Molecular and cellular biology
2025

Association of Dietary Micronutrient Intake and the Metabolome in Children with CKD.

Clinical journal of the American Society of Nephrology : CJASN
2025

Lipidomic Signature of Abdominal Aortic Aneurysm and Peripheral Artery Disease.

Journal of proteome research
2025

Metabolomic profiles of an atherogenic TMAO-dietary pattern among postmenopausal women.

European journal of nutrition
2025

The metabolic signature of salt intake: a cross-sectional analysis from the SCAPIS-study.

Nutrition & metabolism
2025

Alterations in ether lipid metabolism in obesity revealed by systems genomics of multi-omics datasets.

PLoS biology
2025

Associations between 1400 metabolites and subtypes of endometriosis: a two-sample Mendelian randomisation study.

Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology
2025

Brain-region-specific lipid dysregulation in L-DOPA-induced dyskinesia in a primate model of Parkinson's disease.

NPJ Parkinson's disease
2025

Effects of Mytilus edulis derived plasmalogens against atherosclerosis via lipid metabolism and MAPK signaling pathway.

NPJ science of food
2025

Multi-omics characterization of diabetic nephropathy in the db/db mouse model of type 2 diabetes.

Computational and structural biotechnology journal
2025

Lipidome of high-density lipoprotein is strongly perturbed in hyperalphalipoproteinemia resulting from a rare mutation in endothelial lipase.

Atherosclerosis plus
2025

Eggerthella lenta Produces a Cryptic Pro-inflammatory Lipid.

Journal of the American Chemical Society
2025

Plasma and Serum LC-MS Lipidomic Fingerprints of Bipolar Disorder and Schizophrenia.

International journal of molecular sciences
2025

Deleting ACC1 in platelets alters phospholipidome and reduces platelet activation and thrombosis in mice.

Blood advances
2025

SPNS1 variants cause multiorgan disease and implicate lysophospholipid transport as critical for mTOR-regulated lipid homeostasis.

The Journal of clinical investigation
2025

The Circulating Lipidome In Severe Obesity.

medRxiv : the preprint server for health sciences
2025

Visualizing fatigue mechanisms in non-communicable diseases: an integrative approach with multi-omics and machine learning.

BMC medical informatics and decision making
2025

Lipidomic signatures linked to gut microbiota alterations in children and adolescents with type 2 diabetes mellitus and metabolic syndrome.

Scientific reports
2025

Plasmalogen remodeling modulates macrophage response to cytotoxic oxysterols and atherosclerotic plaque vulnerability.

Cell reports. Medicine
2025

Dysregulated metabolic pathways of pulmonary fibrosis and the lipids associated with the effects of nintedanib therapy.

Respiratory research
2025

Neem seed protein hydrolysates alleviate iron-induced cardiac injury via effects on angiotensin-converting enzyme, purinergic enzymes, redox balance, and lipid metabolism.

Archives of physiology and biochemistry
2025

A multi-metabolite signature robustly predicts long-term mortality in the PREDIMED trial and several US cohorts.

Metabolism: clinical and experimental
2025

Influence of Ibuprofen on glycerophospholipids and sphingolipids in context of Alzheimer´s Disease.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
2025

Functional characterization of TMEM86A and TMEM86B mutants by a novel lysoplasmalogenase assay.

Journal of lipid research
2025

Longitudinal Metabolomics in Amyotrophic Lateral Sclerosis Implicates Impaired Lipid Metabolism.

Annals of neurology
2025

Plasmalogens Activate AKT/mTOR Signaling to Attenuate Reactive Oxygen Species Production in Spinal Cord Injury.

Current gene therapy
2025

Molecular cloning, expression, and functional analyses of plasmanylethanolamine desaturase gene of Takifugu rubripes.

Gene
2025

Mid-life anti-inflammatory metabolites are inversely associated with long-term cardiovascular disease events.

EBioMedicine
2024

Plasmalogens Improve Lymphatic Clearance of Amyloid Beta from Mouse Brain and Cognitive Functions.

International journal of molecular sciences
2024

Leishmania major surface components and DKK1 signalling via LRP6 promote migration and longevity of neutrophils in the infection site.

Frontiers in immunology
2024

Determination of Plasmalogen Molecular Species in Hen Eggs.

Molecules (Basel, Switzerland)
2025

Oral Disease and Atherosclerosis May Be Associated with Overlapping Metabolic Pathways.

JDR clinical and translational research
2024

Lipidomics profiling and circulating triglyceride concentrations in sub-Saharan African individuals.

Scientific reports
2024

Metabolomic profiles of incident gallstone disease.

BMJ open gastroenterology
2025

The suppression of nuclear factor kappa B/microRNA 222 axis alleviates lipopolysaccharide-induced acute lung injury through increasing the alkylglyceronephosphate synthase expression.

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy
2024

Synthesis of Plasmalogen Derivatives with Unnatural Fatty Acids as Substrates for Ferroptosis Induction.

ACS chemical biology
2024

Tafazzin deficiency causes substantial remodeling in the lipidome of a mouse model of Barth Syndrome cardiomyopathy.

Frontiers in molecular medicine
2024

A novel inducible animal model for studying chronic plasmalogen deficiency associated with Alzheimer's disease.

Brain research
2024

Volatilome is Inflammasome- and Lipidome-dependent in Ischemic Heart Disease.

Current cardiology reviews
2024

PEX3 promotes regenerative repair after myocardial injury in mice through facilitating plasma membrane localization of ITGB3.

Communications biology
2024

Multifactor Analyses of Frontal Cortex Lipids in the APP/PS1 Model of Familial Alzheimer's Disease Reveal Anomalies in Responses to Dietary n-3 PUFA and Estrogenic Treatments.

Genes
2024

High coverage of targeted lipidomics revealed lipid changes in the follicular fluid of patients with insulin-resistant polycystic ovary syndrome and a positive correlation between plasmalogens and oocyte quality.

Frontiers in endocrinology
2024

Development and validation of a plasmalogen score as an independent modifiable marker of metabolic health: population based observational studies and a placebo-controlled cross-over study.

EBioMedicine
2024

Characterization of phospholipidome in milk, yogurt and cream, and phospholipid differences related to various dairy processing methods.

Food chemistry
2024

Distinctive Lipid Characteristics of Colorectal Cancer Revealed through Non-targeted Lipidomics Analysis of Tongue Coating.

Journal of proteome research
2024

Sea Cucumber Plasmalogen Regulates the Lipid Profile in High-Fat Diet Mouse Liver via Lipophagy.

Journal of agricultural and food chemistry
2024

Sea cucumber plasmalogen enhance lipophagy to alleviate abnormal lipid accumulation induced by high-fat diet.

Biochimica et biophysica acta. Molecular and cell biology of lipids
2024

Plasmalogen, a glycerophospholipid crucial for Streptococcus mutans acid tolerance and colonization.

Applied and environmental microbiology
2024

Length and saturation of choline plasmalogens alter the aggregation rate of α-synuclein but not the toxicity of amyloid fibrils.

International journal of biological macromolecules
2024

Lipid and Transcriptional Regulation in a Parkinson's Disease Mouse Model by Intranasal Vesicular and Hexosomal Plasmalogen-Based Nanomedicines.

Advanced healthcare materials
2024

Parallel Metabolomics and Lipidomics of a PSMA/GCPII Deficient Mouse Model Reveal Alteration of NAAG Levels and Brain Lipid Composition.

ACS chemical neuroscience
2024

Plasma metabolites of a healthy lifestyle in relation to mortality and longevity: Four prospective US cohort studies.

Med (New York, N.Y.)
2024

Tissue-specific roles of peroxisomes revealed by expression meta-analysis.

Biology direct
2024

Protective effect of scallop-derived plasmalogen against vascular dysfunction, via the pSTAT3/PIM1/NFATc1 axis, in a novel mouse model of Alzheimer's disease with cerebral hypoperfusion.

Brain research
2024

Phosphatidylcholine-Plasmalogen-Oleic Acid Reduces BACE1 Expression in Human SH-SY5Y Cells.

Biological & pharmaceutical bulletin
2023

Alterations in lipidome profiles distinguish early-onset hyperuricemia, gout, and the effect of urate-lowering treatment.

Arthritis research & therapy
2023

CSE triggers ferroptosis via SIRT4-mediated GNPAT deacetylation in the pathogenesis of COPD.

Respiratory research
2024

Lipidomic Analysis Reveals Differences in the Extent of Remyelination in the Brain and Spinal Cord.

Journal of proteome research
2024

Neuroprotective effect of plasmalogens on AlCl3-induced Alzheimer's disease zebrafish via acting on the regulatory network of ferroptosis, apoptosis and synaptic neurotransmission release with oxidative stress as the center.

Neuroscience letters
2023

Marine Plasmalogens: A Gift from the Sea with Benefits for Age-Associated Diseases.

Molecules (Basel, Switzerland)
2023

The transcription factor ChREBP links mitochondrial lipidomes to mitochondrial morphology and progression of diabetic kidney disease.

The Journal of biological chemistry
2023

Plasmalogen Improves Memory Function by Regulating Neurogenesis in a Mouse Model of Alzheimer's Diseases.

International journal of molecular sciences
2023

Parkinson's Disease and the Heart: Studying Cardiac Metabolism in the 6-Hydroxydopamine Model.

International journal of molecular sciences
2024

Tumor Lipid Signatures Are Descriptive of Acquisition of Therapy Resistance in an Endocrine-Related Breast Cancer Mouse Model.

Journal of proteome research
2023

Chronic inflammation, neuroglial dysfunction, and plasmalogen deficiency as a new pathobiological hypothesis addressing the overlap between post-COVID-19 symptoms and myalgic encephalomyelitis/chronic fatigue syndrome.

Brain research bulletin
2023

A targeted metabolomics approach for sepsis-induced ARDS and its subphenotypes.

Critical care (London, England)
2023

Utilization of LC-MS/MS and Drift Tube Ion Mobility for Characterizing Intact Oxidized Arachidonate-Containing Glycerophosphatidylethanolamine.

Journal of the American Society for Mass Spectrometry
2024

Complex Hereditary Spastic Paraparesis Caused by de novo p.Arg480Ser in FAR1.

Indian journal of pediatrics
2023

Neonatal rhizomelic chondrodysplasia punctata type 2 caused by a novel homozygous variant in the GNPAT gene.

Clinical case reports
2023

Effects of high-sugar, high-cholesterol, and high-fat diet on phospholipid profile of mouse tissues with a focus on the mechanism of plasmalogen synthesis.

Biochimica et biophysica acta. Molecular and cell biology of lipids
2023

Differential Eye Expression of Xenopus Acyltransferase Gnpat and Its Biochemical Characterization Shed Light on Lipid-Associated Ocular Pathologies.

Investigative ophthalmology & visual science
2023

Several serum lipid metabolites are associated with relapse risk in pediatric-onset multiple sclerosis.

Multiple sclerosis (Houndmills, Basingstoke, England)
2023

Changes in Plasma Neutral and Ether-Linked Lipids Are Associated with The Pathology and Progression of Alzheimer's Disease.

Aging and disease
2023

Systematic crosstalk in plasmalogen and diacyl lipid biosynthesis for their differential yet concerted molecular functions in the cell.

Progress in lipid research
2023

Lipidomics Reveals Elevated Plasmalogens in Women with Obesity Who Develop Preeclampsia.

Journal of clinical medicine
2023

Dietary Protection against Cognitive Impairment, Neuroinflammation and Oxidative Stress in Alzheimer's Disease Animal Models of Lipopolysaccharide-Induced Inflammation.

International journal of molecular sciences
2023

Transcriptomics integrated with metabolomics reveals the ameliorating effect of mussel-derived plasmalogens on high-fat diet-induced hyperlipidemia in zebrafish.

Food & function
2023

Mouse Models to Study Peroxisomal Functions and Disorders: Overview, Caveats, and Recommendations.

Methods in molecular biology (Clifton, N.J.)
2023

Lipidomic profiling of the Brazilian yellow scorpion venom: new insights into inflammatory responses following Tityus serrulatus envenomation.

Journal of toxicology and environmental health. Part A
2023

Prenatal Choline Supplement in a Maternal Obesity Model Modulates Offspring Hepatic Lipidomes.

Nutrients
2023

Cord Blood Plasma Metabolome-wide Associations With Height From Birth to Adolescence.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
2023

Gemfibrozil-Induced Intracellular Triglyceride Increase in SH-SY5Y, HEK and Calu-3 Cells.

International journal of molecular sciences
2023

Overlapping and Distinct Features of Cardiac Pathology in Inherited Human and Murine Ether Lipid Deficiency.

International journal of molecular sciences
2023

a-Synuclein and lipids in erythrocytes of Gaucher disease carriers and patients before and after enzyme replacement therapy.

PloS one
2023

Alterations in ether lipid metabolism and the consequences for the mouse lipidome.

Biochimica et biophysica acta. Molecular and cell biology of lipids
2023

Myelin lipid metabolism and its role in myelination and myelin maintenance.

Innovation (Cambridge (Mass.))
2023

Compartmentalized regulation of lipid signaling in oxidative stress and inflammation: Plasmalogens, oxidized lipids and ferroptosis as new paradigms of bioactive lipid research.

Progress in lipid research
2022

Advances in multi-omics study of biomarkers of glycolipid metabolism disorder.

Computational and structural biotechnology journal
2022

Plasmalogens and platelet-activating factor roles in chronic inflammatory diseases.

BioFactors (Oxford, England)
2023

Plasmalogens inhibit neuroinflammation and promote cognitive function.

Brain research bulletin
2022

The Effect of a Pex3 Mutation on Hearing and Lipid Content of the Inner Ear.

Cells
2022

Relative Abundance of Lipid Metabolites in Spermatozoa across Three Compartments.

International journal of molecular sciences
2022

Dysfunctional peroxisomal lipid metabolisms and their ocular manifestations.

Frontiers in cell and developmental biology
2022

Regulation of plasmalogen metabolism and traffic in mammals: The fog begins to lift.

Frontiers in cell and developmental biology
2022

Cardiac immune cell infiltration associates with abnormal lipid metabolism.

Frontiers in cardiovascular medicine
2022

Vitamin B12 Attenuates Changes in Phospholipid Levels Related to Oxidative Stress in SH-SY5Y Cells.

Cells
2022

Selenoprotein I (selenoi) as a critical enzyme in the central nervous system.

Archives of biochemistry and biophysics
2022

Peroxisomal regulation of energy homeostasis: Effect on obesity and related metabolic disorders.

Molecular metabolism
2022

Ether lipid transfer across the blood-brain and placental barriers does not improve by inactivation of the most abundant ABC transporters.

Brain research bulletin
2022

Decreases of ethanolamine plasmalogen and phosphatidylcholine in erythrocyte are a common phenomenon in Alzheimer's, Parkinson's, and coronary artery diseases.

Brain research bulletin
2022

Plasmalogen in the brain: Effects on cognitive functions and behaviors attributable to its properties.

Brain research bulletin
2022

Molecular insights into peroxisome homeostasis and peroxisome biogenesis disorders.

Biochimica et biophysica acta. Molecular cell research
2022

A Pex7 Deficient Mouse Series Correlates Biochemical and Neurobehavioral Markers to Genotype Severity-Implications for the Disease Spectrum of Rhizomelic Chondrodysplasia Punctata Type 1.

Frontiers in cell and developmental biology
2022

Dietary PUFA Preferably Modify Ethanolamine-Containing Glycerophospholipids of the Human Plasma Lipidome.

Nutrients
2022

The Platelet Lipidome Is Altered in Patients with COVID-19 and Correlates with Platelet Reactivity.

Thrombosis and haemostasis
2022

Plasma Lipid Profiling Identifies Phosphatidylcholine 34:3 and Triglyceride 52:3 as Potential Markers Associated with Disease Severity and Oxidative Status in Chronic Obstructive Pulmonary Disease.

Lung
2022

Impaired Membrane Lipid Homeostasis in Schizophrenia.

Schizophrenia bulletin
2022

EPA-enriched plasmalogen attenuates the cytotoxic effects of LPS-stimulated microglia on the SH-SY5Y neuronal cell line.

Brain research bulletin
2022

Plasmalogens and Photooxidative Stress Signaling in Myxobacteria, and How it Unmasked CarF/TMEM189 as the Δ1'-Desaturase PEDS1 for Human Plasmalogen Biosynthesis.

Frontiers in cell and developmental biology
2022

Tricky Isomers-The Evolution of Analytical Strategies to Characterize Plasmalogens and Plasmanyl Ether Lipids.

Frontiers in cell and developmental biology
2022

Pharmacokinetics, Mass Balance, Excretion, and Tissue Distribution of Plasmalogen Precursor PPI-1011.

Frontiers in cell and developmental biology
2022

First insights into the honey bee (Apis mellifera) brain lipidome and its neonicotinoid-induced alterations associated with reduced self-grooming behavior.

Journal of advanced research
2022

Plasmalogenic Lipid Analogs as Platelet-Activating Factor Antagonists: A Potential Novel Class of Anti-inflammatory Compounds.

Frontiers in cell and developmental biology
2022

Bisphenol A Impairs Lipid Remodeling Accompanying Cell Differentiation in the Oligodendroglial Cell Line Oli-Neu.

Molecules (Basel, Switzerland)
2022

Phosphatidylcholine-Plasmalogen-Oleic Acid Has Protective Effects against Arachidonic Acid-Induced Cytotoxicity.

Biological & pharmaceutical bulletin
2022

Methylxanthines Induce a Change in the AD/Neurodegeneration-Linked Lipid Profile in Neuroblastoma Cells.

International journal of molecular sciences
2022

Hepatoprotective effects of sea cucumber ether-phospholipids against alcohol-induced lipid metabolic dysregulation and oxidative stress in mice.

Food & function
2022

The expanding role of lyso-phosphatidylcholine acyltransferase-3 (LPCAT3), a phospholipid remodeling enzyme, in health and disease.

Current opinion in lipidology
2022

Alterations of Sphingolipid and Phospholipid Pathways and Ornithine Level in the Plasma as Biomarkers of Parkinson's Disease.

Cells
2022

Biomarker profiling of postmortem blood for diabetes mellitus and discussion of possible applications of metabolomics for forensic casework.

International journal of legal medicine
2022

Evidence for Peroxisomal Dysfunction and Dysregulation of the CDP-Choline Pathway in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

medRxiv : the preprint server for health sciences
2022

Using Machine Learning to Identify Metabolomic Signatures of Pediatric Chronic Kidney Disease Etiology.

Journal of the American Society of Nephrology : JASN
2022

Effects of changing from a diet with saturated fat to a diet with n-6 polyunsaturated fat on the serum metabolome in relation to cardiovascular disease risk factors.

European journal of nutrition
2021

Changes in Plasma Phospholipid Metabolism Are Associated with Clinical Manifestations of Systemic Sclerosis.

Diagnostics (Basel, Switzerland)
2021

Impact of Vitamin D3 Deficiency on Phosphatidylcholine-/Ethanolamine, Plasmalogen-, Lyso-Phosphatidylcholine-/Ethanolamine, Carnitine- and Triacyl Glyceride-Homeostasis in Neuroblastoma Cells and Murine Brain.

Biomolecules
2021

Plasmalogens improve swimming performance by modulating the expression of genes involved in amino acid and lipid metabolism, oxidative stress, and ferroptosis in an Alzheimer's disease zebrafish model.

Food & function
2022

Integrative Analysis of the Inflammatory Bowel Disease Serum Metabolome Improves Our Understanding of Genetic Etiology and Points to Novel Putative Therapeutic Targets.

Gastroenterology
2021

Structure-specific, accurate quantitation of plasmalogen glycerophosphoethanolamine.

Analytica chimica acta
2021

AdipoAtlas: A reference lipidome for human white adipose tissue.

Cell reports. Medicine
2021

Dietary Ethanolamine Plasmalogen Alleviates DSS-Induced Colitis by Enhancing Colon Mucosa Integrity, Antioxidative Stress, and Anti-inflammatory Responses via Increased Ethanolamine Plasmalogen Molecular Species: Protective Role of Vinyl Ether Linkages.

Journal of agricultural and food chemistry
2021

Oxidative Stress Linked Organ Lipid Hydroperoxidation and Dysregulation in Mouse Model of Nonalcoholic Steatohepatitis: Revealed by Lipidomic Profiling of Liver and Kidney.

Antioxidants (Basel, Switzerland)
2022

Interplay between cardiolipin and plasmalogens in Barth syndrome.

Journal of inherited metabolic disease
2021

Heat Stress Alters the Intestinal Microbiota and Metabolomic Profiles in Mice.

Frontiers in microbiology
2022

A Prospective Study of Early-pregnancy Thyroid Markers, Lipid Species, and Risk of Gestational Diabetes Mellitus.

The Journal of clinical endocrinology and metabolism
2021

Comprehensive metabolomics profiling reveals common metabolic alterations underlying the four major non-communicable diseases in treated HIV infection.

EBioMedicine
2021

Placental 13C-DHA metabolism and relationship with maternal BMI, glycemia and birthweight.

Molecular medicine (Cambridge, Mass.)
2021

Shotgun lipidomics of liver and brain tissue of Alzheimer's disease model mice treated with acitretin.

Scientific reports
2021

The Ability of Metabolomics to Discriminate Non-Small-Cell Lung Cancer Subtypes Depends on the Stage of the Disease and the Type of Material Studied.

Cancers
2021

Genetic epidemiology approach to estimating birth incidence and current disease prevalence for rhizomelic chondrodysplasia punctata.

Orphanet journal of rare diseases
2021

Shark liver oil supplementation enriches endogenous plasmalogens and reduces markers of dyslipidemia and inflammation.

Journal of lipid research
2021

Different Lipid Signature in Fibroblasts of Long-Chain Fatty Acid Oxidation Disorders.

Cells
2021

Anthracyclins Increase PUFAs: Potential Implications in ER Stress and Cell Death.

Cells
2021

Triple-Knockout, Synuclein-Free Mice Display Compromised Lipid Pattern.

Molecules (Basel, Switzerland)
2021

Alterations of Lipidomes in Rat Photoreceptor Degeneration Induced by N-Methyl-N-nitrosourea.

Lipids
2021

Characterization of brain-derived extracellular vesicle lipids in Alzheimer's disease.

Journal of extracellular vesicles
2021

Compound heterozygous p. Arg949Trp and p. Gly970Ala mutations deteriorated the function of PEX1p: A study on PEX1 in a patient with Zellweger syndrome.

Journal of cellular biochemistry
2021

Nuclear lipidome is altered in amyotrophic lateral sclerosis: A pilot study.

Journal of neurochemistry
2021

Endothelial ether lipids link the vasculature to blood pressure, behavior, and neurodegeneration.

Journal of lipid research
2021

A comparative study on the lipidome of normal knee synovial fluid from humans and horses.

PloS one
2021

Systemic metabolite profiling reveals sexual dimorphism of AIBP control of metabolism in mice.

PloS one
2021

Coronavirus-Induced Host Cubic Membranes and Lipid-Related Antiviral Therapies: A Focus on Bioactive Plasmalogens.

Frontiers in cell and developmental biology
2021

Postmortem Analyses in a Patient With Succinic Semialdehyde Dehydrogenase Deficiency (SSADHD): II. Histological, Lipid, and Gene Expression Outcomes in Regional Brain Tissue.

Journal of child neurology
2021

The Emerging Physiological Role of AGMO 10 Years after Its Gene Identification.

Life (Basel, Switzerland)
2021

Effects of chronic HBV infection on lipid metabolism in non-alcoholic fatty liver disease: A lipidomic analysis.

Annals of hepatology
2021

Lipidomic Analysis of Postmortem Prefrontal Cortex Phospholipids Reveals Changes in Choline Plasmalogen Containing Docosahexaenoic Acid and Stearic Acid Between Cases With and Without Alzheimer's Disease.

Neuromolecular medicine
2021

Effects of Dietary Supplementation with EPA-enriched Phosphatidylcholine and Phosphatidylethanolamine on Glycerophospholipid Profile in Cerebral Cortex of SAMP8 Mice fed with High-fat Diet.

Journal of oleo science
2020

Biological Functions of Plasmalogens.

Advances in experimental medicine and biology
2020

Peroxisome Biogenesis Disorders.

Advances in experimental medicine and biology
2020

7-Ketocholesterol- and 7β-Hydroxycholesterol-Induced Peroxisomal Disorders in Glial, Microglial and Neuronal Cells: Potential Role in Neurodegeneration : 7-ketocholesterol and 7β-hydroxycholesterol-Induced Peroxisomal Disorders and Neurodegeneration.

Advances in experimental medicine and biology
2020

Peroxisome: Metabolic Functions and Biogenesis.

Advances in experimental medicine and biology
2020

Remodeling Lipids in the Transition from Chronic Liver Disease to Hepatocellular Carcinoma.

Cancers
2020

Decrease in Myelin-Associated Lipids Precedes Neuronal Loss and Glial Activation in the CNS of the Sandhoff Mouse as Determined by Metabolomics.

Metabolites
2021

Plasmalogen Biosynthesis by Anaerobic Bacteria: Identification of a Two-Gene Operon Responsible for Plasmalogen Production in Clostridium perfringens.

ACS chemical biology
2020

Metabolic Reprogramming-A New Era How to Prevent and Treat Graft Versus Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation Has Begun.

Frontiers in pharmacology
2021

Clinical, biochemical, and molecular characterization of mild (nonclassic) rhizomelic chondrodysplasia punctata.

Journal of inherited metabolic disease
2021

Lipid alterations in human frontal cortex in ALS-FTLD-TDP43 proteinopathy spectrum are partly related to peroxisome impairment.

Neuropathology and applied neurobiology
2021

An autosomal dominant neurological disorder caused by de novo variants in FAR1 resulting in uncontrolled synthesis of ether lipids.

Genetics in medicine : official journal of the American College of Medical Genetics
2021

Serum phospholipidomics reveals altered lipid profile and promising biomarkers in multiple sclerosis.

Archives of biochemistry and biophysics
2020

Peroxisome Deficiency Impairs BDNF Signaling and Memory.

Frontiers in cell and developmental biology
2020

Early disruption of nerve mitochondrial and myelin lipid homeostasis in obesity-induced diabetes.

JCI insight
2021

Large-Scale Multi-omic Analysis of COVID-19 Severity.

Cell systems
2020

N-Docosahexaenoylethanolamine Attenuates Neuroinflammation and Improves Hippocampal Neurogenesis in Rats with Sciatic Nerve Chronic Constriction Injury.

Marine drugs
2020

Advances in the Biosynthetic Pathways and Application Potential of Plasmalogens in Medicine.

Frontiers in cell and developmental biology
2021

The Degron Architecture of Squalene Monooxygenase and How Specific Lipids Calibrate Levels of This Key Cholesterol Synthesis Enzyme.

Advances in experimental medicine and biology
2020

A lipid-related metabolomic pattern of diet quality.

The American journal of clinical nutrition
2020

Peroxisome quality control and dysregulated lipid metabolism in neurodegenerative diseases.

Experimental & molecular medicine
2020

Comparison of the Diagnostic Performance of C26:0-Lysophosphatidylcholine and Very Long-Chain Fatty Acids Analysis for Peroxisomal Disorders.

Frontiers in cell and developmental biology
2020

Plasmalogens, platelet-activating factor and beyond - Ether lipids in signaling and neurodegeneration.

Neurobiology of disease
2020

1-O-Alkylglycerol accumulation reveals abnormal ether glycerolipid metabolism in Sjögren-Larsson syndrome.

Molecular genetics and metabolism

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Doença da biossíntese dos plasmalogênios.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Doença da biossíntese dos plasmalogênios

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Ordenadas pelo número de sintomas em comum.

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. Plasmalogen deficiency and the Alzheimer's disease risk of apolipoprotein E4.
    Brain communications· 2026· PMID 41768790mais citado
  2. Peroxisomes in Aging: Guardians of Cellular Resilience and Function.
    Cells· 2026· PMID 41677620mais citado
  3. CRISPR knockout screens reveal genes and pathways essential for neuronal differentiation and implicate PEDS1 in neurodevelopment.
    Nature neuroscience· 2026· PMID 41491239mais citado
  4. Lipidomic remodeling of the brain and muscle in a zebrafish model of depression.
    Journal of affective disorders· 2026· PMID 41850615mais citado
  5. Quantification and Localisation of New Brain Lipid Synthesis Using Deuterium Oxide and High Resolution Mass Spectrometry.
    Angewandte Chemie (International ed. in English)· 2026· PMID 41834457mais citado
  6. Neuronal lipidome in schizophrenia and metabolic syndrome: Potential interventions.
    Prog Neuropsychopharmacol Biol Psychiatry· 2026· PMID 41713671recente
  7. Liver Metabolomic Profiling Reveals Distinct Signatures Between Steatosis and Metabolic Dysfunction-Associated Steatohepatitis.
    Liver Int· 2026· PMID 41684045recente
  8. Lipid and immune dysregulation and risk of metabolic disorders after HCV clearance in HIV/HCV-coinfected participants with cACLD: a retrospective study.
    Front Immunol· 2025· PMID 41601646recente
  9. Metabolomic Profiling Reveals Brain Lipid Alterations in PEX7-Deficient Models of Rhizomelic Chondrodysplasia Punctata.
    Biomolecules· 2025· PMID 41594547recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:3276(Orphanet)
  2. MONDO:0017986(MONDO)
  3. GARD:18790(GARD (NIH))
  4. Variantes catalogadas(ClinVar)
  5. Busca completa no PubMed(PubMed)
  6. Q55787665(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Doença da biossíntese dos plasmalogênios
Compêndio · Raras BR

Doença da biossíntese dos plasmalogênios

ORPHA:3276 · MONDO:0017986
🇧🇷 Brasil SUS
Triagem
qPCR para deleção de SMN1 em sangue seco
PNTN
Fase 5
Incidência BR
1:10.000
Geral
MedGen
UMLS
C5681192
Wikidata
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades